Exact Sciences
EXAS
#1209
Rank
NZ$33.10 B
Marketcap
NZ$173.45
Share price
-0.04%
Change (1 day)
94.53%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): NZ-$9.42

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is NZ-$8.92. In 2024 the company made an earnings per share (EPS) of NZ-$9.34.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$9.420.83%
2024NZ-$9.34
2022NZ-$5.942.31%
2021NZ-$5.80-38.54%
2020NZ-$9.44692.96%
2019NZ-$1.19-50.69%
2018NZ-$2.4244%
2017NZ-$1.68-39.39%
2016NZ-$2.77-2.94%
2015NZ-$2.8537.1%
2014NZ-$2.0879.71%
2013NZ-$1.16-21.59%
2012NZ-$1.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
NZ$3.46-138.82%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
NZ$0.65-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.57-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.26-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ-$85.39 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA